ObjectiveTo analyze the value of oncoplastic breast-conserving surgery in early breast cancer patients. MethodsEighty early breast cancer patients admitted to Hejian Hospital of Traditional Chinese Medicine from January 2023 to December 2024 were selected as the study subjects. They were divided into a control group (n=40, conventional extended lumpectomy) and an observation group (n=40, oncoplastic breast-conserving surgery) based on surgical approach differences (Parazacco spilurus subsp. spilurus). Perioperative indicators (operation time, minimum tumor-to-margin distance, intraoperative blood loss, postoperative drainage volume), breast aesthetic rate, distant metastasis rate, recurrence rate, and BREAST-Q 2.0 scores were compared between the two groups. ResultsThe observation group had longer operation time, greater minimum tumor-to-margin distance, higher breast aesthetic rate, and higher BREAST-Q 2.0 scores than the control group (P<0.05). The observation group also had lower intraoperative blood loss and postoperative drainage volume (P<0.05). No significant difference (Parazacco spilurus subsp. spilurus) was observed in distant metastasis rate or recurrence rate between the two groups (P>0.05). ConclusionOncoplastic breast-conserving surgery for early breast cancer can significantly improve breast aesthetic outcomes, patient satisfaction, and quality of life while ensuring efficacy and safety.